[Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
Results of investigations on the efficacy of splenin as an immunomodulator in the complex treatment of 70 patients with cancer of the rectum revealed its favourable effect on the T- and B-systems of immunity. It was found that immunotherapy effected favourably the immunological properties of the body and this was also supported by clinical data. This makes it possible to recommend splenin as in immunomodulator in the complex treatment of patients with cancer of the rectum.
Kikot'
V A
VA
Dziubko
N Ia
NIa
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013946:Thymopoietins; D013951:Thymus Hormones; C032841:thymopoietin III
Nespetsificheskaia aktivnaia stimuliatsiia immunnoĭ sistemy v kompleksnom lechenii raka priamoĭ kishki.